Iterum Therapeutics Stock Forecast

OTC-ITRMF's stock price has decreased by -96.43% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Iterum Therapeutics stock has a target of $9.00, which predicts a 25,614.29% increase from the current stock price of 0.04.

Price Target: $9.00 (+25,614.29%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$9.00	$9.00	$9.00	$9.00
Change	+25614.3%	+25614.3%	+25614.3%	+25614.3%

Analyst Ratings

According to 1 stock analyst, the rating for Iterum Therapeutics is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jun '25	Aug '25	Oct '25	Nov '25	Dec '25	Mar '26
Strong Buy	1	1	1	1	1	0
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Keller H.C. Wainwright	H.C. Wainwright	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Mar 30, 2026
Jason McCarthy Maxim Group	Maxim Group	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Mar 4, 2026

Financial Forecast

Revenue This Year

800.00K

Revenue Next Year

10.00M

from 800.00K

1,150.00%

from 800.00K

EPS This Year

-0.82

from -0.89

EPS Next Year

-0.64

from -0.82

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025
Revenue	-	-	-	-	-	800.00K
Gross Profit	-	-	-	-	-254.00K	400.00K
Operating Income	-32.13M	-24.54M	-30.38M	-47.47M	-18.70M	-25.10M
Net Income	-52.01M	-91.56M	-44.43M	-38.37M	-24.77M	-31.40M
EPS	-	-	-	-	-0.89	-0.82
Free Cash Flow	-8.72M	-28.78M	-13.50M	-21.31M	-19.40M	-18.18M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2025	2026	2027
High	800,000
Avg	800,000
Low	800,000

Revenue Growth

Revenue Growth	2026	2027
High	1,150.0%
Avg	1,150.0%
Low	1,150.0%

EPS Forecast

EPS	2025	2026	2027
High	-
Avg	-0.82
Low	-

EPS Growth

EPS Growth	2025	2026	2027
High	-
Avg	-
Low	-